IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing CABG

NCT01033617 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarct
Heart Failure

Interventions

PROCEDURE: Injection of stem cells at time of coronary artery bypass grafting

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborators

[object Object]
[object Object]
[object Object]